Hims & Hers Health, Inc. Website

Hims & Hers Health, Inc.

NYSE-HIMS

Basic

  • Market Cap

    $3,129.43M

  • EV

    $2,937.66M

  • Shares Out

    214.79M

  • Revenue

    $959.4M

  • Employees

    1,046

Margins

  • Gross

    82.41%

  • EBITDA

    0.54%

  • Operating

    -0.54%

  • Pre-Tax

    0.05%

  • Net

    -0.25%

  • FCF

    6.53%

Returns (5Yr Avg)

  • ROA

    -19.66%

  • ROTA

    -25.21%

  • ROE

    -24.9%

  • ROCE

    -22.82%

  • ROIC

    -98.8%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $16.33

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $203.59M

  • Net Debt

    -$191.77M

  • Debt/Equity

    0.03

  • EBIT/Interest

    —

Growth (CAGR)

  • Rev 3Yr

    77.69%

  • Rev 5Yr

    100.85%

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    -77.49%

  • Dil EPS 5Yr

    -36.83%

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    32%

  • EBITDA Fwd 2Yr

    94.2%

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

82.6

148.8

271.9

526.9

872

959.4

Total Revenues % Chg.

—

209.4%

80.2%

82.8%

93.8%

65.5%

55.7%

Cost of Goods Sold, Total

38

39.3

67.4

118.2

157.1

168.8

Gross Profit

44.6

109.5

204.5

408.7

714.9

790.6

Selling General & Admin Expenses, Total

119

113.4

289.1

445.9

692.7

743

R&D Expenses

—

—

11.2

22.4

29.2

48.2

52.8

Other Operating Expenses, Total

119

124.6

311.4

475.1

741

795.8

Operating Income

-74.4

-15.1

-106.9

-66.4

-26

-5.2

Interest Expense, Total

-0.4

—

—

—

—

—

Interest And Investment Income

1.9

0.4

0.4

2.6

9

9.7

Net Interest Expenses

1.5

0.4

0.4

2.6

9

9.7

Other Non Operating Income (Expenses)

0.9

-3.3

3.9

0.4

-1.1

-0.9

EBT, Excl. Unusual Items

-72

-18

-102.7

-63.4

-18.1

3.6

Asset Writedown

—

—

—

—

-1.1

-0.4

-0.1

Other Unusual Items

—

—

—

-8.1

-1.2

-3

-3

EBT, Incl. Unusual Items

-72

-18

-110.8

-65.7

-21.6

0.5

Income Tax Expense

0.1

0.1

-3.1

-0

2

2.9

Earnings From Continuing Operations

-72.1

-18.1

-107.7

-65.7

-23.5

-2.4

Net Income

-72.1

-18.1

-107.7

-65.7

-23.5

-2.4

Net Income to Common Incl Extra Items

-72.1

-18.1

-107.7

-65.7

-23.5

-2.4

Net Income to Common Excl. Extra Items

-72.1

-18.1

-107.7

-65.7

-23.5

-2.4

Total Shares Outstanding

113.9

116.9

204.8

208.4

213.5

214.4

Weighted Avg. Shares Outstanding

34.8

35.4

186.8

204.5

209.3

210.9

Weighted Avg. Shares Outstanding Dil

34.8

35.4

186.8

204.5

209.3

210.9

EPS

-2.1

-0.5

-0.6

-0.3

-0.1

-0

EPS Diluted

-2.1

-0.5

-0.6

-0.3

-0.1

-0

EBITDA

—

-74.2

-14.1

-102.9

-58.9

-16.5

5.2

Effective Tax Rate

-0.1%

-0.7%

2.8%

0%

-9.2%

558.3%